Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms
•IDCH differs from LCH in its clinical, molecular, and immunohistochemical features.•IDCH is often associated with other hematopoietic neoplasms, and such cases are associated with an inferior prognosis. [Display omitted] Indeterminate dendritic cell histiocytosis (IDCH) is a rare and poorly underst...
Gespeichert in:
Veröffentlicht in: | Blood advances 2024-11, Vol.8 (22), p.5796-5805 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •IDCH differs from LCH in its clinical, molecular, and immunohistochemical features.•IDCH is often associated with other hematopoietic neoplasms, and such cases are associated with an inferior prognosis.
[Display omitted]
Indeterminate dendritic cell histiocytosis (IDCH) is a rare and poorly understood entity characterized by accumulation of CD1a+/S100+ histiocytes (as Langerhans cell histiocytosis [LCH]) but with reduced-absent expression of Langerin/CD207. We assembled 43 cases of IDCH (defined by CD1a+/CD207 |
---|---|
ISSN: | 2473-9529 2473-9537 2473-9537 |
DOI: | 10.1182/bloodadvances.2024013545 |